Member Info for gggg21

I provided my thoughts in the other thread but obviously the sellers and non holders prefer to use this one. 200m mcap is far to cheap simple.

By the way, to win X tender part of the conditions would be to deliver X by X date....hence the stock and then X at another date you could take that they are being maxed out and explains the £10m plus

What an angry sad little man you are paul. Also what is an rna? Glad we can also take you aren't the sharpest TOOL in the box eh

So a little summary as I have just been chatting with some other very knowledgeable novacyt holders and re-reviewing the RNS in detail. I think a lot focused on france and missed the gems and fact Novacyt are making themselves a number of USPs in the diagnostics market and adding even more revenue.
1) Notice the RNS about "sales of the Primerdesign COVID-19 test are €45 million (£40 million)" . This explains the £9m cash as per results when people tried to bash us over it.....we know total orders comes to £120m currently so I think you can quite easily say we will be sat with a very nice cash chunk far far higher than £9m right now and lot more to come, some analysts have realised this.
2) During the second half of the year, additional COVID-19 related sales are expected from the Company's new products, Exsig™ Direct and Exsig™ Mag, and from the Company's mobile testing solution - This is what I will call our new gamechanger and cash cow - I don't think many have realised this and a good holder pointed this out to me...……..exsig direct can be used with any test as long as they use the Genesig master mix. Exsig and exsig mag can be used with any test as it's just a reagent......now think many big boys would like this tech hence why the TM we keep seeing is so important and no doubt we are putting patent in place
3) Mobile testing - The mobile COVID-19 testing solution is a combination of Exsig™ Direct and the COVID-19 test optimised to run on the Company's proprietary q16 and q32 instrumentation. Both Exsig™ extraction reagents are on track to launch during June 2020 and the mobile COVID-19 system will launch in July 2020 - Now yet another revenue stream, these tests can be done in the "field" so think about the potential and they are the gold standard. The q16/q32 go for around £15k a pop so think about that value.....All sports clubs, airports, private business etc. could end up with one.
4) Novacyt is also pleased with the progress it is making in the US market and expects to update the market in due course - This is a specific, we know we have an OEM and we know we are looking for US Sales Manager, a lot more to come of this, join some dots.
5) WHO tenders - I have shared a world aid/governments tender site before, if you sign up you can see all the tender opportunities in progress, a lot more to come.

Strange as i have a friend who has been in hospital 3x now with pregnancy complications (stayed over night each time) at Princess Risborough and has been tested twice each time, entering and leaving when admitted. So 6 tests overall in space of a few weeks.

Correct. I stated that this type of testing will become the normal for the coming years when entering hospital, you will get a tests, before an operation you will get a test and every other day/before you leave hospital a test. So on average every hospital admission will be tested 2-3 times. It will be the normal just like with blood tests etc.

Then add the mobile testing, the contact testing etc. you will see why we are producing 10m plus a month. Stanley how many have avct produced?

Neil would you like to explain 1) To much competition? You do know a lot of the players are losing Abbots and FDA removing approval. There is only a handful of players now and we are gold standard. So please explain your thinking. 2) Testing scaling back? It is actually scaling up, as this is getting life moving again, hence mobile test and UK at 200,000 plus.

Look forward to your detailed response.

Can see who isn’t holding. France opening up nicely

As I posted on twitter. The two keys are the additional revenue coming from new tests and mobile. Keeerching

December sorry multitasking

Yes https://www.euronext.com/en/trade/trading-hours-holidays no more holidays until June over there now

Primerdesign is the U.K. chosen kit. It is not actually 288,000 a week. It is closer to 500,000 a week from novacyt minimum. If you do your research then you will know this. You will also know that the U.K. government is purchasing kit and giving it as aid to other countries as per the Egypt deal. All there in black and white but some prefer to believe swing traders who post on this board and aim to mislead

I would not want to be out of this over the weekend.....can find lots on the internet

Wasn't replying to you sorry anders - was the other poster. I am relaxed, hence why I haven't been posting much. It will all come. 200m mcap quite simply still cheap. From next week we are producing 10m tests a month...…..

What you on about? What you’re looking at is dated.

AGM usually in June to so full presentation all be it via web and then sent to shareholders. Nearly June anyway and dPCR time

Can finally buy again. Been almost impossible for last hour

Fantastic news. What have the shorts got to say now eh.

And every man and his dog knew about Beaufort. It was rife in the city. Was already on the fca radar long before Tom wrote an article and tried to claim glory for it. Sums the fella up.

How are people still talking about him. He copied an article. 9x out of 10 he just copies others and hangs on to their coat tails. Like with boohoo yesterday. Like with burford. Like with nmc. Then uses click bait. He wrote the pathetic article on ncyt himself but tried to draw more in by pretending a better known name had....makes perfect business sense for him to write about the most popular shares...more click bait. Let’s get back to novacyt now and not a self appointed journo, failed fund manager and multiple failed business owner

You got it routy. Now all makes sense for getting up to 10m tests a month capacity in June. The tweet last week on delivery of 300,000 tests for nhs. Capacity in U.K. now at 161,000 a day and the ncyt/astra lighthouse labs online.

Eventually the market will accept this is to cheap when they see the sales figure. Fundamentals see through.